Kevin Li
CIK: 0002158435
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
FLSC
Frazier Life Sciences Acquisition Corp. II
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Li Kevin
Li Kevin (SEC CIK 0002158435) files insider reports with the SEC as Chief Business Officer of Frazier Life Sciences Acquisition Corp. II (FLSC).
Signal8 holds 1 ownership filing by Li Kevin, a Form 3, filed on Oct 13, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Li Kevin's filings is in PALO ALTO, CA.
Other insiders filing for Frazier Life Sciences Acquisition Corp. II (FLSC)
- Cha Albert, Chief Executive Officer
- Adams Francis Sherman, Chief Financial Officer
- Palleiko Benjamin L, Director
- Struthers Richard Scott, Director
- Jackson Alexandra, General Counsel
- Fairey William, Director